COMMUNIQUÉS West-GlobeNewswire

Viveve Appoints Two New Independent Board Members
13/09/2018
ENGLEWOOD, Colo., Sept. 13, 2018 (GLOBE NEWSWIRE) -- Viveve Medical, Inc. (NASDAQ: VIVE), a medical technology company focused on women’s intimate health, today announced that Steve Basta and Karen Zaderej have joined [...]
Cannabco Announces That Proposed Reverse Takeover Will Not Proceed
13/09/2018
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. TORONTO, Sept. 13, 2018 (GLOBE NEWSWIRE) -- [...]
EPSi announces partnership with MPA Healthcare Solutions
13/09/2018
New Performance Analytics for Risk-based Contracts and Medicare Payments to extend EPSi Platform Capabilities CHICAGO, Sept. 13, 2018 (GLOBE NEWSWIRE) -- EPSi, Allscripts (NASDAQ: MDRX) flagship budgeting, long-range [...]
CARsgen Therapeutics and CrownBio complete CAR-T study for gastric cancer
13/09/2018
Claudin18.2 specific CAR-T cells show tumor elimination in PDX models SAN DIEGO, Sept. 13, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, a global drug discovery and development services company providing translational [...]
HealthEC Helps ACO Partners Generate $21.4 Million in Medicare Shared Savings for 2017 Performance Year
13/09/2018
Firm achieves 100% client success rate and helps return more than $9.5 million to customers EDISON, N.J., Sept. 13, 2018 (GLOBE NEWSWIRE) -- HealthEC , a KLAS-recognized end-to-end provider of Population Health [...]
Health Canada Reclassifies Tetra Bio-Pharma’s Inhalation Device Making it Eligible for Reimbursement
13/09/2018
ORLEANS, Ontario, Sept. 13, 2018 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc . (" Tetra " or the " Corporation ") (TSX VENTURE: TBP) (OTCQB: TBPMF), a global leader in cannabinoid-based drug development and discovery, [...]
IBEX Reports Operational Management Changes
13/09/2018
MONTREAL, Sept. 13, 2018 (GLOBE NEWSWIRE) -- IBEX Technologies Inc. (“IBEX” or the “Company”) (TSX Venture: IBT) today reported changes in its operating management ranks. After 25 years of dedicated service Catherine [...]
Delcath Reminds Shareholders that the Rights Offering Subscription Period Expires Wednesday, September 26, 2018
13/09/2018
NEW YORK, Sept. 13, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB: DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, reminds its shareholders of the [...]
Data From Clearside Biomedical’s Pivotal Phase 3 PEACHTREE Clinical Trial in Macular Edema Associated with Non-Infectious Uveitis to be Presented at the Retina Society 51st Annual Scientific Meeting
13/09/2018
ALPHARETTA, Ga., Sept. 13, 2018 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing treatments that restore and preserve vision for people with serious eye [...]
XBiotech Announces Completion and Positive Interim Findings for Initial Cohort in Bermekimab Pilot Study in Atopic Dermatitis
13/09/2018
Company Reports Positive Safety Outcome and Statistically Significant Improvements in Atopic Dermatitis Patients Treated with Low Dose, Short Course of Bermekimab AUSTIN, Texas, Sept. 13, 2018 (GLOBE NEWSWIRE) -- [...]
Large-Scale Global Genome Projects Choose PacBio Sequencing to Help Decode Life
13/09/2018
High-quality reference genomes for thousands of plant, animal and microbial species to be created using SMRT Sequencing MENLO PARK, Calif., Sept. 13, 2018 (GLOBE NEWSWIRE) -- When creating a genomic ark of creatures [...]
Verona Pharma to Host Conference Call to Review Expanded Dataset from RPL554 Phase 2b Clinical Trial in COPD Presented at European Respiratory Society International Congress
13/09/2018
LONDON, Sept. 13, 2018 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for [...]
Solid Biosciences Welcomes Sukumar Nagendran, M.D., To Its Board Of Directors
13/09/2018
CAMBRIDGE, Mass., Sept. 13, 2018 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (NASDAQ: SLDB) today announced that Sukumar Nagendran, M.D., has been elected to its Board of Directors. Dr. Nagendran brings to Solid more [...]
Integrated Cannabis Company, Inc. Develops THC-Infused Spray Product
13/09/2018
VANCOUVER, British Columbia, Sept. 13, 2018 (GLOBE NEWSWIRE) -- Integrated Cannabis Company, Inc. (CSE: ICAN, OTCQB: ICNAF) (the “ Company ” or “ Integrated Cannabis ”), is pleased to announce the completion of a market [...]
BioDelivery Sciences to Host Institutional Investor and Analyst Day on Friday, October 5, 2018
13/09/2018
RALEIGH, N.C., Sept. 13, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing commercial stage specialty pharmaceutical company dedicated to patients living with chronic [...]
ProMIS Neurosciences Appoints James Kupiec, MD as Chief Medical Officer
13/09/2018
Dr. Kupiec to leverage neurodegenerative experience from prior senior positions at Pfizer and Sanofi-Synthelabo TORONTO and CAMBRIDGE, Mass., Sept. 13, 2018 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (TSX: PMN; [...]
BrainStorm Granted New U.S. Patent for Industrial Scale Manufacturing of NurOwn®
13/09/2018
NEW YORK and PETACH TIKVAH, Israel, Sept. 13, 2018 (GLOBE NEWSWIRE) -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today [...]
Helix BioPharma Corp. Initiates Enrollment of the Second Last Cohort in U.S. Combination Treatment Study of Its Lung Cancer Drug Candidate L-DOS47
13/09/2018
RICHMOND HILL, Ontario, Sept. 13, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX, FSE: HBP) ("Helix" or the "Company"), an immuno-oncology company developing innovative drug candidates for the prevention and [...]
Moleculin’s Brain Cancer Drug Candidate Begins Patient Dosing at Clinical Trial Being Conducted at MD Anderson
13/09/2018
Small molecule lead drug candidate blocks a critical target for tumors and crosses the blood brain barrier; begins first brain cancer patient dosing in clinical trial at MD Anderson Cancer Center HOUSTON, Sept. 13, 2018 [...]

Pages